Yibo Wang

August 20, 2025

Cannabidiol alleviates methamphetamine addiction via targeting ATP5A1 and modulating the ATP–ADO–A1R signaling pathway

Abstract Cannabidiol (CBD), a non-psychoactive cannabinoid, shows great promise in treating methamphetamine (METH) addiction. Nonetheless, the molecular target and the…

July 12, 2023

The pharmacology and therapeutic role of cannabidiol in diabetes

Abstract In recent years, cannabidiol (CBD), a non‐psychotropic cannabinoid, has garnered substantial interest in drug development due to its broad…

August 10, 2022

Cannabidivarin alleviates neuroinflammation by targeting TLR4 co-receptor MD2 and improves morphine-mediated analgesia

Abstract Toll-like receptor 4 (TLR4) is a pattern-recognition receptor (PRR) that regulates the activation of immune cells, which is a…